10x Genomics Future Growth

Future criteria checks 1/6

10x Genomics is forecast to grow earnings and revenue by 13.3% and 5.8% per annum respectively. EPS is expected to grow by 14.3% per annum. Return on equity is forecast to be -13.9% in 3 years.

Key information

13.3%

Earnings growth rate

14.3%

EPS growth rate

Life Sciences earnings growth19.8%
Revenue growth rate5.8%
Future return on equity-13.9%
Analyst coverage

Good

Last updated30 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A88 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026694-99-247012
12/31/2025635-149-945816
12/31/2024599-171-1631916
9/30/2024630-1832539N/A
6/30/2024632-240-33-8N/A
3/31/2024625-264-74-27N/A
12/31/2023619-255-65-15N/A
9/30/2023591-223-113-27N/A
6/30/2023568-172-118-11N/A
3/31/2023536-174-126-17N/A
12/31/2022516-166-165-34N/A
9/30/2022504-167-161-42N/A
6/30/2022498-142-161-58N/A
3/31/2022499-89-129-38N/A
12/31/2021490-58-123-21N/A
9/30/2021459-455-253-157N/A
6/30/2021406-504-264-187N/A
3/31/2021333-533-289-219N/A
12/31/2020299-543-256-218N/A
9/30/2020262-134-104-81N/A
6/30/2020251-78-46-11N/A
3/31/2020264-49-1923N/A
12/31/2019246-31-835N/A
9/30/2019221-100-62-23N/A
6/30/2019197-105-69-43N/A
3/31/2019170-105-71-57N/A
12/31/2018146-112-83-76N/A
12/31/201771-19N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A88 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0A88 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0A88 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0A88's revenue (5.8% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0A88's revenue (5.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0A88 is forecast to be unprofitable in 3 years.


Discover growth companies